Published in Lancet Infect Dis on November 17, 2011
Ready for a world without antibiotics? The Pensières Antibiotic Resistance Call to Action. Antimicrob Resist Infect Control (2012) 3.02
Antibiotics induce redox-related physiological alterations as part of their lethality. Proc Natl Acad Sci U S A (2014) 2.25
The antibiotic resistance crisis: part 1: causes and threats. P T (2015) 1.90
Going viral: next-generation sequencing applied to phage populations in the human gut. Nat Rev Microbiol (2012) 1.89
The challenge of efflux-mediated antibiotic resistance in Gram-negative bacteria. Clin Microbiol Rev (2015) 1.81
New antibiotics for bad bugs: where are we? Ann Clin Microbiol Antimicrob (2013) 1.58
Detection of Alpha-Toxin and Other Virulence Factors in Biofilms of Staphylococcus aureus on Polystyrene and a Human Epidermal Model. PLoS One (2016) 1.45
Systematic analysis of funding awarded for antimicrobial resistance research to institutions in the UK, 1997-2010. J Antimicrob Chemother (2013) 1.34
The gut is the epicentre of antibiotic resistance. Antimicrob Resist Infect Control (2012) 1.24
Characterization of the humoral immune response during Staphylococcus aureus bacteremia and global gene expression by Staphylococcus aureus in human blood. PLoS One (2013) 1.08
Investigational antimicrobial agents of 2013. Clin Microbiol Rev (2013) 1.04
How bacterial pathogens eat host lipids: implications for the development of fatty acid synthesis therapeutics. J Biol Chem (2015) 0.99
Oral Phage Therapy of Acute Bacterial Diarrhea With Two Coliphage Preparations: A Randomized Trial in Children From Bangladesh. EBioMedicine (2016) 0.99
Access to antibiotics: a safety and equity challenge for the next decade. Antimicrob Resist Infect Control (2013) 0.90
The antibiotic resistance crisis: part 2: management strategies and new agents. P T (2015) 0.89
Parallel evolutionary pathways to antibiotic resistance selected by biocide exposure. J Antimicrob Chemother (2015) 0.88
Co-occurrence of resistance genes to antibiotics, biocides and metals reveals novel insights into their co-selection potential. BMC Genomics (2015) 0.88
In vitro characterization of the anti-bacterial activity of SQ109 against Helicobacter pylori. PLoS One (2013) 0.87
Development of novel antibacterial drugs to combat multiple resistant organisms. Langenbecks Arch Surg (2015) 0.84
Functional genomics to identify the factors contributing to successful persistence and global spread of an antibiotic resistance plasmid. BMC Microbiol (2014) 0.83
A novel locus for mycelial aggregation forms a gateway to improved Streptomyces cell factories. Microb Cell Fact (2015) 0.83
Cold atmospheric plasma for local infection control and subsequent pain reduction in a patient with chronic post-operative ear infection. New Microbes New Infect (2013) 0.83
Revolutionising bacteriology to improve treatment outcomes and antibiotic stewardship. Infect Chemother (2013) 0.82
Adapting Drug Approval Pathways for Bacteriophage-Based Therapeutics. Front Microbiol (2016) 0.80
Rapid conversion of Pseudomonas aeruginosa to a spherical cell morphotype facilitates tolerance to carbapenems and penicillins but increases susceptibility to antimicrobial peptides. Antimicrob Agents Chemother (2014) 0.80
Roemerine Improves the Survival Rate of Septicemic BALB/c Mice by Increasing the Cell Membrane Permeability of Staphylococcus aureus. PLoS One (2015) 0.79
Three-dimensional QSAR analysis and design of new 1,2,4-oxadiazole antibacterials. Bioorg Med Chem Lett (2015) 0.78
Phytochemicals increase the antibacterial activity of antibiotics by acting on a drug efflux pump. Microbiologyopen (2014) 0.78
Architecture and roles of periplasmic adaptor proteins in tripartite efflux assemblies. Front Microbiol (2015) 0.78
Accumulation of norfloxacin by Mycobacterium aurum and Mycobacterium smegmatis. Antimicrob Agents Chemother (1998) 0.78
Neutral β-Lactams Inactivate High Molecular Mass Penicillin-Binding Proteins of Class B1, Including PBP2a of MRSA. ACS Med Chem Lett (2013) 0.77
The immune response and antibacterial therapy. Med Microbiol Immunol (2014) 0.76
The Widespread Presence of a Multidrug-Resistant Escherichia coli ST131 Clade among Community-Associated and Hospitalized Patients. PLoS One (2016) 0.75
In Vitro and In Vivo Activities of a Bi-Aryl Oxazolidinone, RBx 11760, against Gram-Positive Bacteria. Antimicrob Agents Chemother (2016) 0.75
Save Antibiotics: a call for action of the World Alliance Against Antibiotic Resistance (WAAAR). BMC Infect Dis (2014) 0.75
Comparison of antibacterial effects between antimicrobial peptide and bacteriocins isolated from Lactobacillus plantarum on three common pathogenic bacteria. Int J Clin Exp Med (2015) 0.75
Noninferior Antibiotics: When Is "Not Bad" "Good Enough"? Open Forum Infect Dis (2016) 0.75
New, rapid method to measure dissolved silver concentration in silver nanoparticle suspensions by aggregation combined with centrifugation. J Nanopart Res (2016) 0.75
Screening and characterisation of antimicrobial properties of semisynthetic betulin derivatives. PLoS One (2014) 0.75
Bromomethylthioindole Inspired Carbazole Hybrids as Promising Class of Anti-MRSA Agents. ACS Med Chem Lett (2016) 0.75
Pyroptosis of Salmonella Typhimurium-infected macrophages was suppressed and elimination of intracellular bacteria from macrophages was promoted by blocking QseC. Sci Rep (2016) 0.75
Iron- and Hepcidin-Independent Downregulation of the Iron Exporter Ferroportin in Macrophages during Salmonella Infection. Front Immunol (2017) 0.75
Identification, synthesis and biological activity of alkyl-guanidine oligomers as potent antibacterial agents. Sci Rep (2017) 0.75
Antimicrobial knowledge and confidence amongst final year medical students in Australia. PLoS One (2017) 0.75
Self-medication and antibiotic resistance: Crisis, current challenges, and prevention. Saudi J Biol Sci (2017) 0.75